Cue BiopharmaCUE
13F holders, Q3 2024 (September 30)50holders −25
3new positions
28sold out
1famous investor
$0.76avg. 13F price*
At the end of Q3 2024, 50 institutions reported holding Cue Biopharma Inc. (CUE) in their 13F filings, down 25 from Q2 2024. 3 opened new positions and 28 sold out. The largest holders were Bleichroeder LP ($3.8M), Slate Path Capital LP ($1.8M) and Vanguard Group Inc. ($1.5M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Cue Biopharma Inc.
- CUSIP
- 22978P106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $25K |
| Exits | 28 | $1.3M |
All 13F filers, Q2 2024 → Q3 2024: 2,426,916 shares bought and 2,139,844 shares sold, net +287,072 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 50 holders
| Bleichroeder LP | 1.02% | Add +74.6% | 4,997,240 | $3.8M |
| Slate Path Capital LP | 0.03% | No change | 2,402,455 | $1.8M |
| Vanguard Group Inc. | 0.00% | No change | 2,031,421 | $1.5M |
| BlackRock, Inc. | 0.00% | — | 570,975 | $432K |
| Geode Capital Management, LLC | 0.00% | Add +3.3% | 508,827 | $385K |
| Robertson Stephens Wealth Management, LLC | 0.01% | No change | 478,500 | $362K |
| Sigma Planning Corp | 0.01% | Add +50.9% | 401,325 | $304K |
| Good Life Advisors, LLC | 0.02% | Add +23.1% | 400,000 | $303K |
| Millennium Management | 0.00% | Reduce -27.3% | 358,974 | $272K |
| Gsa Capital Partners LLP | 0.02% | Add +5.1% | 291,663 | $221K |
| Advisory Research Inc. | 0.03% | No change | 257,225 | $195K |
| Bank of America Corp. | 0.00% | Reduce -1.4% | 239,202 | $181K |
| Stifel Financial Corp. | 0.00% | Add +0.1% | 194,222 | $147K |
| State Street Corp. | 0.00% | No change | 177,053 | $134K |
| Northern Trust Corp. | 0.00% | Reduce -60.5% | 138,314 | $105K |
| HighTower Advisors, LLC | 0.00% | No change | 83,284 | $64K |
| UBS Group AG | 0.00% | Add +25.7% | 74,175 | $56K |
| Morgan Stanley | 0.00% | Reduce -72.2% | 33,692 | $26K |
| XTX Topco Ltd | 0.00% | New | 27,665 | $21K |
| Jane Street Group, LLC | 0.00% | Reduce -73.7% | 25,935 | $20K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -69.3% | 24,672 | $19K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.00% | Reduce -54.6% | 24,098 | $18K |
| Wells Fargo & Company | 0.00% | Reduce -2.9% | 20,077 | $15K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Reduce -9.9% | 20,000 | $15K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -93.0% | 18,563 | $14K |
| LPL Financial LLC | 0.00% | No change | 17,925 | $14K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -93.2% | 14,575 | $11K |
| SeaCrest Wealth Management, LLC | 0.00% | No change | 13,000 | $10K |
| Legacy Capital Group California, Inc. | 0.00% | No change | 10,000 | $8K |
| Beacon Pointe Advisors, LLC | 0.00% | No change | 10,000 | $8K |
| Catalyst Funds Management Pty Ltd | 0.00% | No change | 9,000 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -36.6% | 7,217 | $5K |
| Barclays PLC | 0.00% | Reduce -67.0% | 6,029 | $5K |
| Gleason Group, Inc. | 0.00% | No change | 6,000 | $5K |
| Simplex Trading, LLC | 0.00% | New | 4,056 | $3K |
| NFSG Corp | 0.00% | No change | 3,000 | $2K |
| NewEdge Advisors, LLC | 0.00% | No change | 2,550 | $2K |
| Northwestern Mutual Wealth Management Co. | 0.00% | Add +400.0% | 2,500 | $2K |
| Larson Financial Group LLC | 0.00% | New | 1,400 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 904 | $685 |
| BNP Paribas Financial Markets | 0.00% | No change | 801 | $606 |
| Harbour Investments, Inc. | 0.00% | No change | 439 | $332 |
| Osaic Holdings, Inc. | 0.00% | No change | 380 | $288 |
| FMR LLC | 0.00% | Reduce -96.2% | 285 | $216 |
| Sunbelt Securities, Inc. | 0.00% | No change | 237 | $179 |
| Arax Advisory Partners | 0.00% | No change | 215 | $163 |
| Armstrong Advisory Group, Inc. | 0.00% | No change | 120 | $91 |
| IFP Advisors, Inc | 0.00% | No change | 100 | $76 |
| Point72 (DIFC) Ltd | 0.00% | Reduce -99.5% | 58 | $44 |
| Citigroup Inc. | 0.00% | Reduce -99.2% | 43 | $33 |
"% of holder's portfolio" is CUE's weight in each manager's 13F, not the share of Cue Biopharma Inc. the manager owns.